Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential of mesenchymal stromal cells for improving islet transplantation outcomes.

Current opinion in pharmacology - 1 Dec 2018

Rackham Chloe L, Jones Peter M

Abstract excerpt

Allogeneic islet transplantation as a therapy for Type 1 Diabetes (T1D) is restricted by the limited availability of donor islets, loss of functional islets during pre-transplantation culture in vitro and further extensive loss during the immediate post-transplantation period when islet function and survival is compromised by the hypoxic, inflammatory host environment. In the longer term pathogenic T cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Graft Rejection
Share to Graft Survival
Share to Islets of Langerhans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Islets of Langerhans Transplantation

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Recovery of Function

Share to Regeneration

Source

Identifiers

PMID: 30103073
DOI: 10.1016/j.coph.2018.07.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential of mesenchymal stromal cells for improving islet transplantation outcomes.PMID 30103073Read ↗

Secretome analysis of human and rat pancreatic islets co-cultured with adipose-derived stromal cells reveals a signature with enhanced regenerative capacitiesSemantic proximity Read ↗

Therapeutic potential of mesenchymal stem cells for diabetes.Semantic proximity Read ↗

The Current Status of Allogenic Islet Cell TransplantationSemantic proximity Read ↗

Divergent Cell-Type Specific Hypoxia Responses in Human Stem Cell–Derived and Primary IsletsSemantic proximity Read ↗

Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 DiabetesSemantic proximity Read ↗

Stem cells as a therapeutic target for diabetesSemantic proximity Read ↗

Novel Treatment Modalities of Type 1 Diabetes Mellitus: Opportunities and ChallengesSemantic proximity Read ↗

Human pancreatic islet-derived stromal cells reveal combined features of mesenchymal stromal cells and pancreatic stellate cellsSemantic proximity Read ↗

Co-transplantation with mesenchymal stem cells and endothelial cells improvise islet engraftment and survival in STZ treated hyperglycemic miceSemantic proximity Read ↗

Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic ProgenitorsSemantic proximity Read ↗

Concise Review: Pluripotent Stem Cell-Based Regenerative Applications for Failing β-Cell FunctionSemantic proximity Read ↗

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.